Zhejiang Shouxiangu Pharm Co Strategic Asset Allocation Index
Zhejiang Shouxiangu Pharm Co strategic asset allocation index. Zhejiang Shouxiangu Pharm Co (603896) has a Strategic Asset Allocation Index of 28.0% as of June 2023. Strategic assets (PP&E of CN¥562.91 Million plus long-term investments of CN¥-) total CN¥562.91 Million, measured against net assets of CN¥2.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Zhejiang Shouxiangu Pharm Co balance sheet quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Zhejiang Shouxiangu Pharm Co (2012–2022)
Strategic asset allocation index of Zhejiang Shouxiangu Pharm Co from 2012 to 2022. This chart shows how Zhejiang Shouxiangu Pharm Co's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 28.0%, representing strategic assets of CN¥562.91 Million against net assets of CN¥2.01 Billion CNY. Check tangible net worth ratio of Zhejiang Shouxiangu Pharm Co to evaluate the tangible quality of the company's equity base.
Zhejiang Shouxiangu Pharm Co Strategic Asset Allocation Index by Year (2012–2022)
Zhejiang Shouxiangu Pharm Co strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Shouxiangu Pharm Co from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zhejiang Shouxiangu Pharm Co (603896) total market value.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 31.5% | CN¥601.14 Million | CN¥601.14 Million | CN¥- | CN¥1.91 Billion | ▼ -0.3 pp |
| 2021 | 31.8% | CN¥515.91 Million | CN¥515.91 Million | CN¥- | CN¥1.62 Billion | ▲ +3.7 pp |
| 2020 | 28.2% | CN¥373.66 Million | CN¥373.66 Million | CN¥- | CN¥1.33 Billion | ▲ +1.9 pp |
| 2019 | 26.3% | CN¥308.29 Million | CN¥308.29 Million | CN¥- | CN¥1.17 Billion | ▼ -0.9 pp |
| 2018 | 27.2% | CN¥268.07 Million | CN¥268.07 Million | CN¥- | CN¥984.74 Million | ▲ +7.4 pp |
| 2017 | 19.9% | CN¥172.81 Million | CN¥172.81 Million | CN¥- | CN¥869.75 Million | ▼ -33.3 pp |
| 2016 | 53.2% | CN¥232.28 Million | CN¥232.28 Million | CN¥- | CN¥436.93 Million | ▼ -11.6 pp |
| 2015 | 64.7% | CN¥238.57 Million | CN¥238.57 Million | CN¥- | CN¥368.53 Million | ▲ +6.5 pp |
| 2014 | 58.2% | CN¥186.71 Million | CN¥186.71 Million | CN¥- | CN¥320.56 Million | ▲ +16.1 pp |
| 2013 | 42.1% | CN¥126.21 Million | CN¥126.21 Million | CN¥- | CN¥299.50 Million | ▼ -20.7 pp |
| 2012 | 62.9% | CN¥86.99 Million | CN¥86.99 Million | CN¥- | CN¥138.37 Million | — |